PAHC: Phibro Animal Health Enterprise Value to EBITDA Ratio

Corporate company logo of pahc.com (PAHC)

The veterinary pharmacy development strategy strengthens the financial profile of Phibro Animal Health (PAHC). The company's trend EV/EBITDA level demonstrates stability, where the 8.44 mark reflects the current valuation of the asset. Business reliability is based on proprietary feed additives and the loyalty of a high-caliber staff of biologists, ensuring sustainable capital flows and global food security.

PAHC Phibro Animal Health Corp: Business Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/12/2026

pahc.com (PAHC) - metric breakdowns and financial figures

- stock price and consensus target price:
Stock Quotes Phibro|PAHC - Analyst Forecast Prices
- market capitalization information:
Market Valuation Phibro Animal Health Inc.|PAHC - Enterprise Value
- business book valuation details:
Net Assets per Single Share Phibro Animal Health|PAHC - Accounting Value of Company|Market Capitalization to Book Value Ratio pahc.com|PAHC - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Phibro Animal Health|PAHC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Phibro Animal Health Corporation|PAHC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Phibro Animal Health Inc.|PAHC - Company Long-Term Loans and Borrowings|Company Short-Term Debts Phibro Animal Health|Quick Liquidity pahc.com
- business earnings and investment ratios data:
PAHC - Net Financial Result|Expected Profit Phibro Animal Health|PAHC - Market Cap to Earnings|Projected Price to Earnings Phibro Animal Health|PAHC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Phibro Animal Health Inc.|PAHC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Phibro Animal Health|PAHC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth pahc.com|PAHC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Phibro Animal Health
Summary company analysis:PAHC (Phibro)
Original product of Phibro Animal Health Corp

Conservative capital requires asset value transparency, accounting for debt load and tax liabilities, to confirm business sustainability. This indicator compares the total enterprise value with its operating profit, allowing for an assessment of the real price of cash flow generation regardless of the financing structure. Stable demand for Phibro Animal Health (PAHC) veterinary products confirms the company's fundamental value, which is clearly reflected in the business's EV/EBITDA history.

Key competitors

Corteva Inc - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NTR (Nutrien Corp)|CF: Enterprise Value to EBITDA Ratio|MOS - EV/EBITDA Multiple|Elanco (ELAN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Balchem Corp - Business Value to Operating Income Before Depreciation|FMC (FMC Corp.) - EV/EBITDA Multiple|EV/EBITDA Multiple scottsmiraclegro.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CVR Partners, LP (UAN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ODC (Oil-Dri Corporation of America)|Intrepid Potash - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation LVRO|AVD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GRO (Brazil Potash Inc)|ICCC: EV/EBITDA Multiple|Company Value to EBITDA cgagri.com (ENFY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Origin Agritech Ltd.|China Green Agriculture Inc. (CGA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization S&W Seed Company, Inc. (SANW)